{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:29:19Z","timestamp":1786350559640,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["10-IAHU-0006"],"award-info":[{"award-number":["10-IAHU-0006"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00415-026-13945-4","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:05:41Z","timestamp":1784156741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epilepsy and disability in adults with tuberous sclerosis complex: a 16-year retrospective analysis"],"prefix":"10.1007","volume":"273","author":[{"given":"Quentin","family":"Calonge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Hanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eblle","family":"Dade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gourfinkel-An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0077-8114","authenticated-orcid":false,"given":"Vincent","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"1","key":"13945_CR1","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske EP, J\u00f3\u017awiak S, Kingswood JC, Sampson JR, Thiele EA (2016) Tuberous sclerosis complex. Nat Rev Dis Primers 2(1):16035. https:\/\/doi.org\/10.1038\/nrdp.2016.35","journal-title":"Nat Rev Dis Primers"},{"issue":"21","key":"13945_CR2","doi-asserted-by":"publisher","first-page":"13571","DOI":"10.1073\/pnas.202476899","volume":"99","author":"AR Tee","year":"2002","unstructured":"Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J (2002) Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 99(21):13571\u201313576. https:\/\/doi.org\/10.1073\/pnas.202476899","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"13945_CR3","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/hmg\/6.12.2155","volume":"6","author":"AC Jones","year":"1997","unstructured":"Jones AC et al (1997) Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet 6(12):2155\u20132161. https:\/\/doi.org\/10.1093\/hmg\/6.12.2155","journal-title":"Hum Mol Genet"},{"issue":"7","key":"13945_CR4","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","volume":"51","author":"CJ Chu\u2010Shore","year":"2010","unstructured":"Chu\u2010Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA (2010) The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 51(7):1236\u20131241. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02474.x","journal-title":"Epilepsia"},{"issue":"23","key":"13945_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235495","volume":"10","author":"D Miszewska","year":"2021","unstructured":"Miszewska D, Sugalska M, J\u00f3\u017awiak S (2021) Risk factors associated with refractory epilepsy in patients with tuberous sclerosis complex: a systematic review. J Clin Med 10(23):5495. https:\/\/doi.org\/10.3390\/jcm10235495","journal-title":"J Clin Med"},{"key":"13945_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812448437","author":"B Lennert","year":"2013","unstructured":"Lennert B, Farrelly E, Sacco P, Pira G, Frost M (2013) Resource utilization in children with tuberous sclerosis complex and associated seizures: a retrospective chart review study. J Child Neurol. https:\/\/doi.org\/10.1177\/0883073812448437","journal-title":"J Child Neurol"},{"issue":"1","key":"13945_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","volume":"52","author":"PJ De Vries","year":"2015","unstructured":"De Vries PJ et al (2015) Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist. Pediatr Neurol 52(1):25\u201335. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2014.10.004","journal-title":"Pediatr Neurol"},{"issue":"1","key":"13945_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL et al (2001) Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68(1):64\u201380. https:\/\/doi.org\/10.1086\/316951","journal-title":"Am J Hum Genet"},{"issue":"1","key":"13945_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/ane.13416","volume":"144","author":"A Vignoli","year":"2021","unstructured":"Vignoli A et al (2021) Epilepsy in adult patients with tuberous sclerosis complex. Acta Neurol Scand 144(1):29\u201340. https:\/\/doi.org\/10.1111\/ane.13416","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"13945_CR10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ajhg.2023.04.002","volume":"110","author":"K Klonowska","year":"2023","unstructured":"Klonowska K et al (2023) Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex. Am J Hum Genet 110(6):979\u2013988. https:\/\/doi.org\/10.1016\/j.ajhg.2023.04.002","journal-title":"Am J Hum Genet"},{"issue":"11","key":"13945_CR11","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/s41436-019-0562-6","volume":"21","author":"K Giannikou","year":"2019","unstructured":"Giannikou K et al (2019) Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission. Genet Med 21(11):2639\u20132643. https:\/\/doi.org\/10.1038\/s41436-019-0562-6","journal-title":"Genet Med"},{"key":"13945_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup H et al (2021) Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol 123:50\u201366. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.07.011","journal-title":"Pediatr Neurol"},{"issue":"3","key":"13945_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/dmcn.14356","volume":"62","author":"C Tye","year":"2020","unstructured":"Tye C et al (2020) Long\u2010term cognitive outcomes in tuberous sclerosis complex. Dev Med Child Neurol 62(3):322\u2013329. https:\/\/doi.org\/10.1111\/dmcn.14356","journal-title":"Dev Med Child Neurol"},{"key":"13945_CR14","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2305-5839.2015.12.63","author":"Z Zhang","year":"2016","unstructured":"Zhang Z (2016) Multiple imputation with multivariate imputation by chained equation (MICE) package. Ann Transl Med. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.12.63","journal-title":"Ann Transl Med"},{"issue":"1","key":"13945_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/epi4.12286","volume":"4","author":"R Nabbout","year":"2019","unstructured":"Nabbout R et al (2019) Epilepsy in tuberous sclerosis complex: findings from the TOSCA study. Epilepsia Open 4(1):73\u201384. https:\/\/doi.org\/10.1002\/epi4.12286","journal-title":"Epilepsia Open"},{"issue":"3","key":"13945_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/epi.17159","volume":"63","author":"K Bachour","year":"2022","unstructured":"Bachour K et al (2022) Adults with tuberous sclerosis complex: a distinct patient population. Epilepsia 63(3):663\u2013671. https:\/\/doi.org\/10.1111\/epi.17159","journal-title":"Epilepsia"},{"key":"13945_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yebeh.2018.03.006","volume":"82","author":"HM Hamer","year":"2018","unstructured":"Hamer HM et al (2018) Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers. Epilepsy Behav 82:64\u201367. https:\/\/doi.org\/10.1016\/j.yebeh.2018.03.006","journal-title":"Epilepsy Behav"},{"issue":"1","key":"13945_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13023-019-1258-3","volume":"15","author":"JP Z\u00f6llner","year":"2020","unstructured":"Z\u00f6llner JP et al (2020) A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC). Orphanet J Rare Dis 15(1):23. https:\/\/doi.org\/10.1186\/s13023-019-1258-3","journal-title":"Orphanet J Rare Dis"},{"issue":"30","key":"13945_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016402","volume":"98","author":"W Xue-Ping","year":"2019","unstructured":"Xue-Ping W, Hai-Jiao W, Li-Na Z, Xu D, Ling L (2019) Risk factors for drug-resistant epilepsy: a systematic review and meta-analysis. Medicine 98(30):e16402. https:\/\/doi.org\/10.1097\/MD.0000000000016402","journal-title":"Medicine"},{"issue":"14","key":"13945_CR20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1177\/0883073817737446","volume":"32","author":"A Jeong","year":"2017","unstructured":"Jeong A, Nakagawa JA, Wong M (2017) Predictors of drug-resistant epilepsy in tuberous sclerosis complex. J Child Neurol 32(14):1092\u20131098. https:\/\/doi.org\/10.1177\/0883073817737446","journal-title":"J Child Neurol"},{"key":"13945_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2023.2216385","author":"G Prezioso","year":"2023","unstructured":"Prezioso G, Chiarelli F, Matricardi S (2023) Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review. Expert Rev Neurother. https:\/\/doi.org\/10.1080\/14737175.2023.2216385","journal-title":"Expert Rev Neurother"},{"key":"13945_CR22","doi-asserted-by":"publisher","unstructured":"on behalf of TOSCA consortium and TOSCA investigators et al (2017) TuberOus SClerosis registry to increase disease Awareness (TOSCA) \u2013 baseline data on 2093 patients. Orphanet J Rare Dis 12(1):2. https:\/\/doi.org\/10.1186\/s13023-016-0553-5","DOI":"10.1186\/s13023-016-0553-5"},{"issue":"12","key":"13945_CR23","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1111\/epi.12430","volume":"54","author":"A Vignoli","year":"2013","unstructured":"Vignoli A et al (2013) Epilepsy in TSC: certain etiology does not mean certain prognosis. Epilepsia 54(12):2134\u20132142. https:\/\/doi.org\/10.1111\/epi.12430","journal-title":"Epilepsia"},{"issue":"1","key":"13945_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ana.26778","volume":"95","author":"EM Bebin","year":"2024","unstructured":"Bebin EM et al (2024) Early treatment with vigabatrin does not decrease focal seizures or improve cognition in tuberous sclerosis complex: the prevent trial. Ann Neurol 95(1):15\u201326. https:\/\/doi.org\/10.1002\/ana.26778","journal-title":"Ann Neurol"},{"issue":"2","key":"13945_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.25956","volume":"89","author":"K Kotulska","year":"2021","unstructured":"Kotulska K et al (2021) Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial. Ann Neurol 89(2):304\u2013314. https:\/\/doi.org\/10.1002\/ana.25956","journal-title":"Ann Neurol"},{"issue":"3","key":"13945_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00381-019-04066-7","volume":"35","author":"G G\u00fcl Mert","year":"2019","unstructured":"G\u00fcl Mert G et al (2019) Factors affecting epilepsy prognosis in patients with tuberous sclerosis. Childs Nerv Syst 35(3):463\u2013468. https:\/\/doi.org\/10.1007\/s00381-019-04066-7","journal-title":"Childs Nerv Syst"},{"issue":"9","key":"13945_CR27","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/epi.13467","volume":"57","author":"A Jeong","year":"2016","unstructured":"Jeong A, Wong M (2016) Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex. Epilepsia 57(9):1443\u20131449. https:\/\/doi.org\/10.1111\/epi.13467","journal-title":"Epilepsia"},{"issue":"10056","key":"13945_CR28","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA French","year":"2016","unstructured":"French JA et al (2016) Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. The Lancet 388(10056):2153\u20132163. https:\/\/doi.org\/10.1016\/S0140-6736(16)31419-2","journal-title":"The Lancet"},{"issue":"2","key":"13945_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/brain\/awz411","volume":"143","author":"S Liu","year":"2020","unstructured":"Liu S et al (2020) Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China. Brain 143(2):570\u2013581. https:\/\/doi.org\/10.1093\/brain\/awz411","journal-title":"Brain"},{"issue":"9","key":"13945_CR30","doi-asserted-by":"publisher","first-page":"e214260","DOI":"10.1212\/WNL.0000000000214260","volume":"105","author":"Z Wei","year":"2025","unstructured":"Wei Z et al (2025) Resective surgery for drug-resistant epilepsy in patients with tuberous sclerosis complex: a prospective nationwide multicenter cohort study. Neurology 105(9):e214260. https:\/\/doi.org\/10.1212\/WNL.0000000000214260","journal-title":"Neurology"},{"key":"13945_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2025.110380","volume":"166","author":"C Toscano-Prat","year":"2025","unstructured":"Toscano-Prat C et al (2025) Cognitive and neuro-psychiatric profile in adult patients with epilepsy secondary to tuberous sclerosis complex. Epilepsy Behav 166:110380. https:\/\/doi.org\/10.1016\/j.yebeh.2025.110380","journal-title":"Epilepsy Behav"},{"issue":"4","key":"13945_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/epi4.12365","volume":"4","author":"M Vergeer","year":"2019","unstructured":"Vergeer M et al (2019) Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex. Epilepsia Open 4(4):581\u2013592. https:\/\/doi.org\/10.1002\/epi4.12365","journal-title":"Epilepsia Open"},{"key":"13945_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2024.06.012","volume":"159","author":"LS Farach","year":"2024","unstructured":"Farach LS et al (2024) Drug-resistant epilepsy in tuberous sclerosis complex is associated with TSC2 genotype: more findings from the preventing epilepsy using vigatrin (PREVeNT) trial. Pediatr Neurol 159:62\u201371. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2024.06.012","journal-title":"Pediatr Neurol"},{"issue":"11","key":"13945_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005637","volume":"11","author":"ME Tyburczy","year":"2015","unstructured":"Tyburczy ME et al (2015) Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet 11(11):e1005637. https:\/\/doi.org\/10.1371\/journal.pgen.1005637","journal-title":"PLoS Genet"},{"issue":"11","key":"13945_CR35","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1038\/s41436-019-0520-3","volume":"21","author":"AM Treichel","year":"2019","unstructured":"Treichel AM et al (2019) Phenotypic distinctions between mosaic forms of tuberous sclerosis complex. Genet Med 21(11):2594\u20132604. https:\/\/doi.org\/10.1038\/s41436-019-0520-3","journal-title":"Genet Med"},{"issue":"5","key":"13945_CR36","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ejhg.2011.241","volume":"20","author":"AM Van Eeghen","year":"2012","unstructured":"Van Eeghen AM, Black ME, Pulsifer MB, Kwiatkowski DJ, Thiele EA (2012) Genotype and cognitive phenotype of patients with tuberous sclerosis complex. Eur J Hum Genet 20(5):510\u2013515. https:\/\/doi.org\/10.1038\/ejhg.2011.241","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"13945_CR37","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1093\/brain\/awad048","volume":"146","author":"E Aronica","year":"2023","unstructured":"Aronica E, Specchio N, Luinenburg MJ, Curatolo P (2023) Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy. Brain 146(7):2694\u20132710. https:\/\/doi.org\/10.1093\/brain\/awad048","journal-title":"Brain"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13945-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:49:36Z","timestamp":1786348176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13945-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["13945"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13945-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.B. received honorarium from Jazz Pharma, UCB pharma and Biocodex for Advisory boards. I.GA received honorarium from Jazz Pharma and UCB Pharma for Advisory boards and conferences. V.N received honorarium from UCB pharma, EISAI, Jazz Pharma, Angellini, Neuraxpharm France for Advisory boards and conferences. All other authors declare no other conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board and received authorization from the French data protection authority (CNIL; approval number 2211991).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"465"}}